FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/044000 [Registered on: 14/07/2022] Trial Registered Prospectively
Last Modified On: 10/07/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Ayurvedic Approach For Type-2 Diabetes Mellitus 
Scientific Title of Study   A Comparative Study Of Chandra Kala Gudika And Bougainvillea-Annona Patra Ghana Vati in Madhumeha (Type-2 Diabetes Mellitus) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neha Upadhyay 
Designation  P G Scholar 
Affiliation  Rishikul Campus, Uttarakhand Ayurveda University 
Address  P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  9917782541  
Fax    
Email  nehau0020@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr OP Singh 
Designation  Professor 
Affiliation  Rishikul Campus Uttarakhand Ayurveda University Haridwar 
Address  P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  9411503035  
Fax    
Email  dr.opsingh63@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr OP Singh 
Designation  Professor 
Affiliation  Rishikul Campus Uttarakhand Ayurveda University Haridwar 
Address  P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  9411503035  
Fax    
Email  dr.opsingh63@gmail.com  
 
Source of Monetary or Material Support  
Dr Neha Upadhyay, P.G Department of Kayachikitsa Rishikul Campus Haridwar 
 
Primary Sponsor  
Name  Dr Neha Upadhyay 
Address  P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar 249401 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Neha Upadhyay  P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar 249401 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neha Upadhyay  Rishikul Campus Uttarakhand Ayurveda University Haridwar  P.G Department of Kayachikitsa Rishikul Campus Uttarakhand Ayurveda University Haridwar
Hardwar
UTTARANCHAL 
9917782541

nehau0020@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Uttarakhand Ayurveda University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: TYPE2 DIABETES MELLITUS, (2) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: Madhumeha,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugOther than Classical(1) Medicine Name: Bougainvillea Annona Patra Ghana Vati, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -Luke Warm Water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Chandra Kala Gudika, Reference: Bhaishajya Ratnavali, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: Luke Warm Water), Additional Information:
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Fasting blood glucose level>110mg/dl<250mg/dl.
2.Post prandial blood sugar level>140mg/dl<350mg/dl.
3.Patients between the age group of 30-60 years.
4.Chronicity-max. upto 5 years. 
 
ExclusionCriteria 
Details  1.Patients of Type 1 Diabetes Mellitus.
2.Age below 30 years and above 60 years.
3.Blood sugar-fasting blood sugar level>250mg/dl.
4.Post Prandial blood sugar level>350mg/dl.
5.Patients having complications.
6.Patients suffering from any serious medical or surgical illness.
7.Chronic Diabetic patients (chronicity more than 5 years.). 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in sign and symptoms of MADHUMEHA (TYPE2 DIABETES MELLITUS) are Prabhoot mutrata, Avil mutrata, Ati-kshudha, Pipasa-adhikya, Karpada-daha, Daurbalya.  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in-
1.BloodSugar-Fasting
2.BloodSugar-Post-Prandial
3.HbA1c
4.Urine Sugar
5.BMI 
90 Days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/07/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Madhumeha is one among 20 types of prime(urological disorder) described in various Ayurvedic classics. Excess use of guru,snigdha,amla,and lavana,navanna, asya-sukha,atinindra,avyaam obtaining from samshodhana therapy are the major cause of madhumeha. All these factors lead to imbalance of Dosha cause Mandyaagni formation of ama dosga which increase kleda and also lead to margaavran.Due to Chedana, Lekhana, Medohara, Mootral, Shothar, Balya, Pramehaghan properties of CHANDRA KALA GUDIKA AND BOUGAINVILLEA ANNONA PATRA have taken for the study. 
Close